Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,

Slides:



Advertisements
Similar presentations
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Advertisements

Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
National Prostate Cancer Audit Julie Nossiter, Project Manager Clinical Effectiveness Unit – Royal College of Surgeons.
NPCA data submission and reporting
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
Merseyside and Cheshire Cancer Network HEPATO BILIARY MULTIDISCIPLINIARY TEAM MEETING Referral to Specialist HPB (Liver) MDT, University Hospital, Aintree,
National Prostate Cancer Audit: Review of the Organisational Audit Dr Ajay Aggarwal Oncology Coordinator NPCA Honorary.
National Oesophago–Gastric Cancer Audit Comparing local and national figures.
National Cancer Registry Luxembourg EUROCHIP-3 Meeting Ispra, 27 th February 2012 Olivier Collignon, PhD, Sophie Couffignal, MD, CRP-Santé.
The LCA: Implementing a Quality Assurance and Informatics Strategy to Enhance Cancer Care Dr Shelley Dolan LCA Clinical Director.
ISB Notice and preparing for the implementation of the new IAPT Data Standard Shaun Crowe Mental Health, Employment and IAPT Mental Health Collaborative.
Using routine data to measure recurrence in Head and Neck Cancer Zi Wei Liu Matt Williams Adam Gibson Kate Ricketts Heather Fitzke Imperial.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
Healthcare in the UK Margaret Costello – Gorlin Syndrome Group.
The National Mastectomy and Breast Reconstruction Audit Key findings of the Third Annual Report Slides produced by the MBR Project Team. © The National.
Audit of EGFR mutation testing in patients with proven Non-Small Cell Lung Cancer On behalf of the North of England Cancer Network Lung NSSG Dr Naomi Chamberlin,
National Bowel Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP:
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.
Steps towards measuring Equity in Testing Dr Mark Kroese UKGTN Public Health Advisor UK Genetic Testing Network Conference 22 nd November 2012.
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 YSBYTY MAELOR WREXHAM (BCUHB) MDT.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
As the data flows… The data collection process Matthew Jones (Southend Renal Unit) David Bull (Renal Registry)
National Oesophago-Gastric Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP: |
Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.
Measuring progress towards delivery of the target Ken Nicholson, ISD.
Skin Cancer Network Group Audit of Clinical Performance Indicators: Data quality and treatment quality Anna Murray BSc Cancer Information Analyst
Radiotherapy Data Collection Helen Forbes National Cancer Services Analysis Team.
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 CTUHB (Royal Glamorgan and Price Charles Hospitals) MDT.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
Network Audit Patients with Confirmed Small Cell Lung Cancer Who Did Not Receive Chemotherapy Dr D N Leitch On Behalf of Lung Cancer NSSG NECN.
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
What data are available, and how are they accessed?
Cancer Outcomes and Services Dataset What is COSD? Implications for Providers and Networks.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
Heart Failure Audit Dr Jenny Welstand Lead Nurse Heart Failure Service Wrexham Maelor Hospital Acknowledgements: North Wales Cardiac Network Dr Richard.
What data are collected? How, and who by? Karen Graham and Barry Plewa.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2015 Comparison of (Your site name) results against the national results.
WALES BREAST CANCER CLINICAL AUDIT (WBCCA) MDT DATA FOR PATIENTS DIAGNOSED in 2009, 2010 and 2011 Llandough Hospital (Cardiff and Vale UHB) MDT.
How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
What data are collected? How, and who by?. It’s complicated… ONS data.
Oesophago–Gastric Cancer Audit
Brain imaging prior to lung cancer resection
National Bowel Cancer Audit
Oesophago–Gastric Cancer
National Oesophago–Gastric Cancer Audit 2015.
National Diabetes Audit – An Overview
HANA Audit Update for SSG
Systemic Anti Cancer Therapy (SACT) Cancer 52 Ralphael Oghagbon
Oesophago–Gastric Cancer
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 PRINCE CHARLES HOSPITAL (PCH) MDT.
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 YSBYTY GLAN CLWYD (YGC) MDT.
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 BRONGLAIS HOSPITAL (BRONGLAIS) MDT.
Lung Cancer Audit to patient Reference Group
Healthy London Partnership
Hannah Marder Cancer Manager UH Bristol
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
2018 National Mesothelioma Audit
Breast Cancer SSG 14th November
28 Day Faster Diagnosis Standard
MDT scorecard – using routine data to reduce unwarranted variations
Lung Cancer (C33-C34): 2011 Proportion of Cases Diagnosed at Each Stage, Adults (Aged 15-99), England and Wales Stage Adults Stage I 14.5% Stage II 7.3%
National Lung Cancer Audit
Presentation transcript:

Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist, NWCN

LUCADA  Healthcare Commission sponsored  Run by NCASP  UK National Audit  All newly diagnosed lung cancer patients  Date first seen 01/01/2006 to 31/12/2006  Malignant disease only (not in situ disease)  Year 1: 2005 data headline indicators only  Year 2: 2006 date full clinical data

2005 data England / Wales comparison Outcome Headline indicatorWalesEngland Number of cases Proportion of lung cancer patients who have specific anti-cancer treatment 59%39% Proportion of lung cancer patients in whom there is a histological and / or cytological diagnosis 75%64% Proportion of lung cancer patients who have been reviewed by an MDT 90%81% Proportion of lung cancer patients who underwent surgical resection -8%

Submission process Year 2 Mapping LUCADA ~ CANISC Apr 07 Information Pack to teams 30/4/07 Weekly nagging s! Teams validating data 14/06/07 Data extract run centrally 18/6/07 Central validation 18-28/6/07 Submission to LUCADA 29/6/07

Summary: – excellent data completeness  NHS no  Date first seen  Date of diagnosis  ICD10 disease coding  Basis of Diagnosis  Histology recorded  MDT discussion indicator

Summary: room for improvement  Pre-treatment TNM staging  Significant co-morbidity  Performance status  1 st definitive treatment entered

LUCADA next steps … …  Improve data completeness key items  Continue with regular validation checks of data  Move towards Prospective data collection

Any Questions?